NeuroPace, Inc.
General ticker "NPCE" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $408.4M (TTM average)
NeuroPace, Inc. follows the US Stock Market performance with the rate: 51.9%.
Estimated limits based on current volatility of 2.4%: low 16.20$, high 16.99$
Factors to consider:
- Total employees count: 184 (+7.6%) as of 2024
- Countries other than US accounted for 0.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Regulatory and compliance, Cybersecurity threats, Labor/talent shortage/retention, Manufacturing challenges and quality control
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [10.31$, 22.39$]
- 2026-12-31 to 2027-12-31 estimated range: [9.45$, 20.85$]
Financial Metrics affecting the NPCE estimates:
- Negative: with PPE of -24.2 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.06 > -0.60
- Positive: Inventory ratio change, % of 0.52 <= 0.78
- Positive: Interest expense per share per price, % of 1.43 <= 3.31
Short-term NPCE quotes
Long-term NPCE plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $65.42MM | $79.91MM | $99.99MM |
| Operating Expenses | $92.59MM | $101.58MM | $116.32MM |
| Operating Income | $-27.17MM | $-21.67MM | $-16.34MM |
| Non-Operating Income | $-5.78MM | $-5.47MM | $-5.13MM |
| Interest Expense | $8.52MM | $8.80MM | $7.46MM |
| R&D Expense | $20.78MM | $23.65MM | $27.89MM |
| Income(Loss) | $-32.96MM | $-27.14MM | $-21.46MM |
| Net Income(Loss)* | $-32.96MM | $-27.14MM | $-21.46MM |
| Stockholders Equity | $20.65MM | $8.01MM | $19.03MM |
| Inventory | $11.21MM | $13.38MM | $16.90MM |
| Assets | $107.65MM | $94.65MM | $105.56MM |
| Operating Cash Flow | $-19.70MM | $-17.95MM | $-11.01MM |
| Capital expenditure | $0.17MM | $0.31MM | $0.33MM |
| Investing Cash Flow | $23.03MM | $8.99MM | $-0.33MM |
| Financing Cash Flow | $8.13MM | $4.33MM | $19.60MM |
| Earnings Per Share** | $-1.27 | $-0.93 | $-0.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.